MICHELE DELZER: Open Payments
NPI 1508910985 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,514 in 67 payments from 16 companies in 2025. Trend: 2023 $407 · 2024 $1,034 · 2025 $1,514
Food & beverage: $1,514
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $244 |
| ABBVIE INC. | 17 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $174 |
| HARMONY BIOSCIENCES LLC | 8 | $156 |
| Madrigal Pharmaceuticals | 1 | $144 |
| Teva Pharmaceuticals USA, Inc. | 6 | $124 |
| Lundbeck LLC | 4 | $100 |
| Alkermes, Inc. | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
Products named: Auvelity, CAPLYTA, WAKIX, VRAYLAR, REZDIFFRA, REXULTI, AUSTEDO XR, LYBALVI.
Industry payments across SD — which companies pay providers there.
